By: Fadwa Abdel, Bhubaneshwar Borooah, Kaushik Jagannath, Jose R. Reyes, Barbara Ann, Marc Vincent
The risk of radiotherapy-treated brain metastasis (BrM) in gastrointestinal (GI) cancers is poorly defined. We aimed to determine its incidence and develop a clinically interpretable prediction model.



